News

AFFiRiS Announces FDA Response to its pre-IND Submission for Phase 2 Trial with AFFITOPE® PD01 in Early Parkinson’s Disease Patients

Scientists from EUCODIS contributed to research published in Nature Catalysis

TAmiRNA bringing senescence biomarker insights to Longevity Therapeutics Summit

Marinomed Biotech AG / Shareholders offer shares by way of an accelerated bookbuilding

Lexogen Releases Scalable 12 nt Unique Dual Index System with Enhanced Error Correction for Multiplexing of up to 384+ RNA-Seq Libraries

Internationale Partnersuche: Wissenschaft und Wirtschaft beim „blind date“

How decisions unfold in a zebrafish brain

AVVie GmbH Austria ("Angel Valve") Achieved Important Milestone Completing 90 Days Chronic Animal Trial for Their Mitral Butterfly® Design

Von Willebrand factor antigen for assessing the urgency of a liver transplant

Petra Heffeter and Walter Berger are MedUni Vienna's Inventors of the Year 2019

Valneva: US DoD Exercises Option on IXIARO® Supply Contract Bringing Total Value to $70 Million

Autophagie: Recycling-Zentrum der Pflanzen erforscht

GBA Group Pharma (ABF) Completes Expansion and Scale-Up Project in Anticipation of Brexit

Grazer Forscher präsentieren Beurteilungsskala für seltenen Immundefekt

Pharmig begrüßt Regierungsprogramm

AFFiRiS announces Phase 2 study in Parkinson’s and new focus on neurodegenerative diseases

Valneva Expands its Commercial Operations with the Opening of its French Commercial Office

QuantSeq-UMI Pipeline is Now Available on Partek® Flow®

Im Takt: Neue Therapie bei Herzinsuffizienz im Forschungsvisier

Valneva Announces End of Phase 2 Meeting with the FDA for its Chikungunya Vaccine Candidate